Sam Slutsky

Stock Analyst at LifeSci Capital

(2.80)
# 1,677
Out of 5,109 analysts
3
Total ratings
66.67%
Success rate
56.76%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sam Slutsky

Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $105.83
Upside: -14.96%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45$101
Current: $145.31
Upside: -30.49%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $1.14
Upside: -